Drug Trial Radar · NCT05949593
Phase 3, Randomized, Placebo-Controlled Study of Tinlarebant to Explore Safety and Efficacy in Geographic Atrophy
Last checked: Nov 19, 2026Latest source record: Jan 7, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
429
Planned (sponsor's estimate)
Start
Jul 27, 2023
Primary completion
Jun 30, 2027
Study completion Aug 31, 2027
Sponsor
- Lead sponsor
- Belite Bio, IncIndustry
- Sponsor type
- Industry
- First posted
- Jul 18, 2023
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 60 years, up to 85 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This Phase 3, multicenter, double-masked, parallel-group, placebo-controlled, randomized, fixed-dose clinical study is designed to evaluate the efficacy and safety of tinlarebant (LBS-008) in subjects diagnosed with GA.
Conditions
- Geographic Atrophy
Interventions
TinlarebantDrug
5 mg tablet taken orally once a day
PlaceboDrug
Placebo tablets for tinlarebant 5 mg prepared similarly.
Primary outcomes
What the sponsor says the trial is designed to measure.
- To measure the rate of change (growth rate slope) in geographic atrophy (GA) lesion sizeTime frame: From baseline to Month 24]
Locations
49 sites in 8 countries. Site status is shown where the registry gives one.
Belite Study Site
Phoenix, Arizona
Belite Study Site
Arcadia, California
Belite Study Site
Beverly Hills, California
Belite Study Site
Huntington Beach, California
Belite Study Site
Los Angeles, California
Belite Study Site
Palo Alto, California
Belite Study Site
San Diego, California
Belite Study Site
Lakeland, Florida
Belite Study Site
Hagerstown, Maryland
Belite Study Site
Saint Louis Park, Minnesota
Belite Study Site
Westbury, New York
Belite Study Site
Cary, North Carolina
Belite Study Site
Durham, North Carolina
Belite Study Site
Wake Forest, North Carolina
Belite Study Site
Portland, Oregon
Belite Study Site
Philadelphia, Pennsylvania
Belite Study Site
Sewickley, Pennsylvania
Belite Study Site
Germantown, Tennessee
Belite Study Site
Abilene, Texas
Belite Study Site
Dallas, Texas
Belite Study Site
San Antonio, Texas
Belite Study Site
Warrenton, Virginia
Belite Study Site
Chatswood, New South Wales, Australia
Belite Study Site
Strathfield, New South Wales, Australia
Belite Study Site
Brisbane, Queensland, Australia
Belite Study Site
Adelaide, South Australia, Australia
Belite Study Site
East Melbourne, Victoria, Australia
Belite Study Site
Crawley, Western Australia, Australia
Belite Study Site
Beijing, China
Belite Study Site
Beijing, China
Belite Study Site
Guandong, China
Belite Study Site
Zhejiang, China
Belite Study Site
Beijing, Beijing Municipality, China
Belite Study Site
Chengdu, Sichuan, China
Belite Study Site
Ostrava, Czechia
Belite Study Site
Prague, Czechia
Belite Study Site
Prague, Czechia
Belite Study Site
Dijon, France
Belite Study Site
Écully, France
Belite Study Site
Lyon, France
Showing 40 of 49 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.